281 related articles for article (PubMed ID: 11837539)
1. The cellular pathology of Parkinson's disease.
Takahashi H; Wakabayashi K
Neuropathology; 2001 Dec; 21(4):315-22. PubMed ID: 11837539
[TBL] [Abstract][Full Text] [Related]
2. [The mechanism of Lewy body formation in Parkinson's disease].
Wakabayashi K; Takahashi H
Nihon Rinsho; 2000 Oct; 58(10):2022-7. PubMed ID: 11068441
[TBL] [Abstract][Full Text] [Related]
3. Synphilin-1 is present in Lewy bodies in Parkinson's disease.
Wakabayashi K; Engelender S; Yoshimoto M; Tsuji S; Ross CA; Takahashi H
Ann Neurol; 2000 Apr; 47(4):521-3. PubMed ID: 10762166
[TBL] [Abstract][Full Text] [Related]
4. Controversy: is Parkinson's disease a single disease entity? Yes.
Takahashi H; Wakabayashi K
Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S31-7. PubMed ID: 15885626
[TBL] [Abstract][Full Text] [Related]
5. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
Jellinger KA
Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
[TBL] [Abstract][Full Text] [Related]
6. Immunocytochemical localization of synphilin-1, an alpha-synuclein-associated protein, in neurodegenerative disorders.
Wakabayashi K; Engelender S; Tanaka Y; Yoshimoto M; Mori F; Tsuji S; Ross CA; Takahashi H
Acta Neuropathol; 2002 Mar; 103(3):209-14. PubMed ID: 11907799
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease.
Liani E; Eyal A; Avraham E; Shemer R; Szargel R; Berg D; Bornemann A; Riess O; Ross CA; Rott R; Engelender S
Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5500-5. PubMed ID: 15064394
[TBL] [Abstract][Full Text] [Related]
8. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.
Irizarry MC; Growdon W; Gomez-Isla T; Newell K; George JM; Clayton DF; Hyman BT
J Neuropathol Exp Neurol; 1998 Apr; 57(4):334-7. PubMed ID: 9600226
[TBL] [Abstract][Full Text] [Related]
9. Alpha-synuclein-positive structures in association with diffuse neurofibrillary tangles with calcification.
Hishikawa N; Hashizume Y; Ujihira N; Okada Y; Yoshida M; Sobue G
Neuropathol Appl Neurobiol; 2003 Jun; 29(3):280-7. PubMed ID: 12787325
[TBL] [Abstract][Full Text] [Related]
10. Synphilin isoforms and the search for a cellular model of lewy body formation in Parkinson's disease.
Eyal A; Engelender S
Cell Cycle; 2006 Sep; 5(18):2082-6. PubMed ID: 16969096
[TBL] [Abstract][Full Text] [Related]
11. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
[TBL] [Abstract][Full Text] [Related]
12. Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease.
Mezey E; Dehejia AM; Harta G; Tresser N; Suchy SF; Nussbaum RL; Brownstein MJ; Polymeropoulos MH
Mol Psychiatry; 1998 Nov; 3(6):493-9. PubMed ID: 9857974
[TBL] [Abstract][Full Text] [Related]
13. Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies.
Trimmer PA; Borland MK; Keeney PM; Bennett JP; Parker WD
J Neurochem; 2004 Feb; 88(4):800-12. PubMed ID: 14756800
[TBL] [Abstract][Full Text] [Related]
14. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M
Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110
[TBL] [Abstract][Full Text] [Related]
15. The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates.
Wakabayashi K; Tanji K; Mori F; Takahashi H
Neuropathology; 2007 Oct; 27(5):494-506. PubMed ID: 18018486
[TBL] [Abstract][Full Text] [Related]
16. Widespread occurrence of argyrophilic glial inclusions in Parkinson's disease.
Hishikawa N; Hashizume Y; Yoshida M; Sobue G
Neuropathol Appl Neurobiol; 2001 Oct; 27(5):362-72. PubMed ID: 11679088
[TBL] [Abstract][Full Text] [Related]
17. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.
Conway KA; Harper JD; Lansbury PT
Biochemistry; 2000 Mar; 39(10):2552-63. PubMed ID: 10704204
[TBL] [Abstract][Full Text] [Related]
18. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.
Baba M; Nakajo S; Tu PH; Tomita T; Nakaya K; Lee VM; Trojanowski JQ; Iwatsubo T
Am J Pathol; 1998 Apr; 152(4):879-84. PubMed ID: 9546347
[TBL] [Abstract][Full Text] [Related]
19. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208
[TBL] [Abstract][Full Text] [Related]
20. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.
Spillantini MG; Crowther RA; Jakes R; Cairns NJ; Lantos PL; Goedert M
Neurosci Lett; 1998 Jul; 251(3):205-8. PubMed ID: 9726379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
